(redirected from Vitrasert)
Also found in: Medical.
Related to Vitrasert: ganciclovir implant


 (găn-sī′klō-vîr′, -klə-)
A synthetic nucleoside analog, C9H13N5O4, derived from guanine and used in the prevention and treatment of opportunistic cytomegalovirus infections.

[gan-, origin unknown + -ciclovir, antiviral drug suffix (from acyclovir).]


n ganciclovir m
References in periodicals archive ?
Vitrasert and Retisert (Bausch & Lomb, USA) are clinically used non-biodegradable implants.
pSivida also has two products approved by the Food and Drug Administration (FDA): Retisert for the treatment of uveitis and Vitrasert for the treatment of AIDS-related cytomegalovirus (CMV) retinitis.
The B&L line of branded prescription products includes the steroid eyedrops Lotemax, Alrex and Zylet, and Retisert and Vitrasert to treat retinal diseases.